Lidocaine in Refractory Status Epilepticus: Confirmation of Efficacy with Continuous EEG Monitoring
Authors:
Abstract
Summary: Lidocaine was efficacious in 2 patients with refractory status epilepticus (RSE) unresponsive to several antiepileptic drugs (AEDs), including high‐dose barbiturates. We confirmed the efficacy of lidocaine with, for the first time in adults, continuous EEG monitoring. Lidocaine, when properly used, may be a treatment option in RSE.Keywords
This publication has 22 references indexed in Scilit:
- Lidocaine in Refractory Status Epilepticus: Confirmation of Efficacy with Continuous EEG MonitoringEpilepsia, 1992
- Hippocampal Pyramidal Cell Loss in Human Status EpilepticusEpilepsia, 1992
- Emergency Management of Seizures: An OverviewEpilepsia, 1989
- Intravenous Lidocaine for Status EpilepticusEpilepsia, 1988
- Hypothermia and barbiturate coma for refractory status epilepticusCritical Care Medicine, 1984
- Management of Status EpilepticusNew England Journal of Medicine, 1982
- Nonconvulsive Status Epilepticus following Generalized Tonic-Clonic SeizuresEuropean Neurology, 1982
- LidocaineSouthern Medical Journal, 1979
- Intravenous lidocaine in the treatment of convulsions1978
- INTRAVENOUS LIGNOCAINE AS AN ANTICONVULSANT IN STATUS EPILEPTICUS AND SERIAL EPILEPSYThe Lancet, 1958